$33.13 -0.26 (%) Cempra Inc - NASDAQ

Jul. 6, 2015 | 09:40 AM

Partner Headlines

  1. CNBC's Stock Pops & Drops From February 26

    Benzinga | Feb. 27, 2015 | 06:55AM EST
  2. Fast Money Picks For February 23: Facebook, Cempra And More

    Benzinga | Feb. 23, 2015 | 06:32AM EST
  3. Benzinga's Top Initiations

    Benzinga | Feb. 10, 2015 | 09:15AM EST
  4. Janney Capital Initiates Cempra At Buy

    Benzinga | Feb. 10, 2015 | 09:07AM EST
  5. Does Cempra Have The Next Blockbuster Drug?

    GuruFocus | Jan. 8, 2015 | 12:06PM EST
  6. 4 More Biotech Secondaries Investors Are Watching

    Benzinga | Jan. 7, 2015 | 12:50PM EST
  7. Monday's After-Hours Market Movers

    Benzinga | Jan. 5, 2015 | 18:53PM EST
  8. Benzinga's Volume Movers

    Benzinga | Jan. 5, 2015 | 10:38AM EST
  9. Mid-Morning Market Update: Markets Open Lower; General Motors U.S. Sales Surge 19%

    Benzinga | Jan. 5, 2015 | 10:28AM EST
  10. Stocks Hitting 52-Week Highs

    Benzinga | Jan. 5, 2015 | 10:24AM EST
  11. Morning Market Movers

    Benzinga | Jan. 5, 2015 | 09:47AM EST
  12. Monday #PreMarket Movers: Conatus Pharmaceuticals, Brainstorm Cell Therapeutics And More

    Benzinga | Jan. 5, 2015 | 09:31AM EST
  13. 5 Stocks To Watch On The First Day Of 2015

    Benzinga | Jan. 1, 2015 | 14:38PM EST
  14. 3 Companies To Watch On Social Media This New Year's Eve

    Benzinga | Dec. 31, 2014 | 11:02AM EST
  15. Benzinga's Volume Movers

    Benzinga | Dec. 31, 2014 | 10:35AM EST
  16. UPDATE: Stifel Reiterates Raises PT On Cempra On Good Risk/Reward Profile

    Benzinga | Dec. 31, 2014 | 07:31AM EST
  17. Cellceutix Corp Shares Rise On Two Catalysts

    Benzinga | Dec. 9, 2014 | 09:28AM EST
  18. Mid-Day Gainers From December 8: Cubist Pharmaceuticals, Acceleron Pharma, Calithera Biosciences, Cempra, Isis Pharmaceuticals

    Benzinga | Dec. 8, 2014 | 13:00PM EST
  19. Pharmaceutical Stocks In Play Following Merck/Cubist Deal

    Benzinga | Dec. 8, 2014 | 09:09AM EST
  20. US Stock Futures Flat; Fed Minutes In Focus

    Benzinga | Nov. 19, 2014 | 07:23AM EST
  21. Morning Market Losers

    Benzinga | Sep. 29, 2014 | 09:48AM EST
  22. Cempra Completes Enrollment of Solitaire-Oral Phase 3 Trial

    Benzinga | Sep. 25, 2014 | 16:05PM EST
  23. Cempra, Inc. Receives $10M Milestone Payment From Toyama Chemical Co. Triggered By Solithromycin's Clinical Development Progress In Japan

    Benzinga | Sep. 9, 2014 | 08:03AM EST
  24. Events Scheduled for Week of Jun 23rd to Jun 27th, 2014

    Benzinga | Jun. 23, 2014 | 18:25PM EST
  25. Benzinga's Top Initiations

    Benzinga | Apr. 8, 2014 | 08:53AM EST
  26. UPDATE: Leerink Swann Reiterates on Cempra Driven by Solithromycin Updates

    Benzinga | Nov. 18, 2013 | 11:14AM EST
  27. Cempra's CEM-101 Wins Qualified Infectious Disease Product Designation from FDA

    Benzinga | Sep. 6, 2013 | 08:03AM EST
  28. Cempra Inc. Doses First Patients in Solithromycin (CEM-101) Phase 2 Trial in Uncomplicated Urogenital Gonococcal Infections

    Benzinga | Jun. 12, 2012 | 02:05AM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!